Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46,377,939
-
Number of holders
-
100
-
Total 13F shares, excl. options
-
20,292,672
-
Shares change
-
-152,936
-
Total reported value, excl. options
-
$362,569,441
-
Value change
-
-$2,721,250
-
Number of buys
-
38
-
Number of sells
-
-51
-
Price
-
$17.87
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q3 2017
112 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q3 2017.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 100 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20,292,672 shares
of 46,377,939 outstanding shares and own 43.76% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5,512,455 shares), VANGUARD GROUP INC (2,392,195 shares), DIMENSIONAL FUND ADVISORS LP (1,558,113 shares), Invesco Ltd. (1,336,330 shares), FEDERATED INVESTORS INC /PA/ (1,049,402 shares), STATE STREET CORP (952,638 shares), TEACHERS ADVISORS, LLC (549,149 shares), NORTHERN TRUST CORP (479,618 shares), UBS ASSET MANAGEMENT AMERICAS INC (471,344 shares), and Bank of New York Mellon Corp (456,156 shares).
This table shows the top 100 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.